Using in vitro cultures of the human hepatoma cell line HepG2 as a model system to study modulation of LDLR expression, we found that triciribine, a highly specific inhibitor of AKT kinases, induces the expression of LDLR through augmentation of its mRNA stability. Here, LDLR is linked to hepatocellular carcinoma.